Real-World Biomarker Testing Patterns in Patients With Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in a US Community-Based Oncology Practice Setting-Reference-Cited by-同舟云学术

Real-World Biomarker Testing Patterns in Patients With Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in a US Community-Based Oncology Practice Setting

Published:2023-07 Issue:5 Volume:24 Page:429-436
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Sireci Anthony N.,Krein Peter M.,Hess Lisa M.^ORCID,Khan Taha,Willey Joanne,Ayars Michael,Deyoung Kathryn,Bhaskar Sandhya,Mumuney Ganiat,Coutinho Anna

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Cancer Statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2016. 2019.

3. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification;Travis;J Thorac Oncol,2015

4. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT);Barlesi;Lancet North Am Ed,2016

5. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with next generation sequencing-based testing among patients with advanced/metastatic non-squamous non-small cell lung cancer: A study using machine learning methods (Preprint);2024-07-16

2. Value of next generation sequencing (NGS) testing in advanced cancer patients;Journal of Medical Economics;2024-04-02

3. Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types;The Journal of Molecular Diagnostics;2024-04

4. RET Fusion Testing in Patients With NSCLC: The RETING Study;JTO Clinical and Research Reports;2024-04

5. Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion;Advances in Therapy;2023-10-06